Jun 29, 2022 | CMT Research Updates, Stories
Recently Cleary Simpson (CEO), Keith Fargo (Chief Scientific Officer) and Susan Ruediger (Co-founder and Chief Mission Officer) traveled to San Diego for the annual BIO International Convention. BIO (Biotechnology Innovation Organization) brings together thousands of...
Apr 11, 2022 | About CMT, CMT Research Updates
Nearly every instance of CMT is caused by the mutation of a single gene and most genetic causes of CMT have been identified. The era of genetic medicine has already begun. The FDA first approved genetic medicines in 2016/2017. This set the foundation for a precision...
Dec 31, 2021 | Uncategorized
2021 has been a banner year for progress in CMT drug development, much of which has been possible because of your partnership with the CMT Research Foundation – thank you! Despite the challenges presented by a global pandemic, we can be proud of all that we were able...
Jul 20, 2021 | CMT Research Updates, CMTRF Funded Research, Life with CMT, News, Stories
An Interview with RareCast’s Danny Levine Part of our mission at CMT Research Foundation is to raise awareness about the progress we are making in finding a cure for CMT in the medical, scientific, pharma and patient communities. So, I was pleased to be...
Jul 18, 2021 | CMT Research Updates, News, Research news
Professor Marina Kennerson who directs the team at the Northcott Neuroscience Laboratory, ANZAC Research Institute in Sydney Australia is one of the lead researchers awarded a $3 million grant from the Medical Research Future Fund (MRFF) Genomics Health Futures...
Important Research News Announcements